Prognostic Value of Serum Copper for Post-Stroke Clinical Recovery: A Pilot Study
Open Access
- 30 May 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 9, 333
Abstract
The clinical course after ischemic stroke can vary considerably despite similar lesions and clinical status at the onset of symptoms, suggesting that individual factors modulate clinical recovery. Here, we sought to test the working hypothesis that elevated copper values provide prognostic information, and specifically predict worse clinical recovery. We further sought to support previous findings regarding metal metabolism in acute stroke. We assessed total antioxidant status, oxidative stress factors (peroxides) and metal metabolism markers (iron, copper, ceruloplasmin concentration and activity, ferritin, and transferrin) in the acute phase (2–10 days from symptom onset) in 30 patients affected by unilateral middle cerebral artery (MCA) stroke. A longitudinal assessment of clinical deficit was performed in the acute and stabilized phases (typically 6 months post-stroke) using the National Institutes of Health Stroke Scale (NIHSS). In identifying recovery-related factors, we considered effective recovery (ER), calculated as the ratio between actual NIHSS recovery and the total potential recovery. This allows an estimation of the actual recovery adjusted for the patient’s initial condition. In the acute phase, clinical severity was correlated with increased peroxide concentrations, and lower iron levels. Less successful clinical recovery was correlated with increased acute copper levels, which entered a multiple regression model that explained 24% of ER variance. These pilot data suggest that, in the acute phase of an ischemic stroke, copper may provide useful information about clinical recovery.Keywords
This publication has 41 references indexed in Scilit:
- Ischemic Cerebral DamageStroke, 2012
- Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute StrokeStroke, 2009
- DP-b99, a Membrane-Activated Metal Ion Chelator, as Neuroprotective Therapy in Ischemic StrokeStroke, 2008
- Ironing-Out Mechanisms of Neuronal Injury under Hypoxic–Ischemic Conditions and Potential Role of Iron Chelators as Neuroprotective AgentsAntioxidants & Redox Signaling, 2000
- Low Molecular Weight Iron in Cerebral Ischemic Acidosis In VivoStroke, 1998
- Copper Modulation of NMDA Responses in Mouse and Rat Cultured Hippocampal NeuronsEuropean Journal of Neuroscience, 1996
- Hypoxia Alters Iron Homeostasis and Induces Ferritin Synthesis in OligodendrocytesJournal of Neurochemistry, 1995
- Excitotoxic cell deathJournal of Neurobiology, 1992
- Measurement of motor recovery after stroke. Outcome assessment and sample size requirements.Stroke, 1992
- Efficiency, effectiveness, and duration of stroke rehabilitation.Stroke, 1990